Home versus in-centre haemodialysis for end-stage kidney disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Palmer, Suetonia C ^a   Palmer, Andrew R ^b   Craig, Jonathan C ^c,d   Johnson, David W ^e   Stroumza, Paul ^f   Frantzen, Luc ^f   Leal, Miguel ^g   Hoischen, Susanne ^h   Hegbrant, Jorgen ⁱ   Strippoli, Giovanni F M ^c,j,k  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f Les Jardins de Castellane   (France)

^g Medical Office   (Portugal)

^h Medical Office   (Germany)

ⁱ Diaverum Renal Services Group   (Sweden)

^j MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^k Medical Scientific Office   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CALCIUM; HEMOGLOBIN; PHOSPHORUS;

ANEMIA; BACTEREMIA; BLOOD PRESSURE MONITORING; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; END STAGE RENAL DISEASE; FATIGUE; GRAFT RECIPIENT; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HOME DIALYSIS; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MORTALITY RATE; PAIN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; SELF CARE; SEXUAL DYSFUNCTION; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SURVIVAL RATE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT DURATION; UREMIA; VASCULAR ACCESS; ADULT; BLOOD PRESSURE; KIDNEY FAILURE, CHRONIC; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME;

ADULT; BLOOD PRESSURE; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TIME FACTORS;

EID: 84922223566     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009535.pub2     Document Type: Review

References (111)

1. McGregor DO, Buttimore AL, Lynn KL, Nicholls MG, Jardine DL. A comparative study of blood pressure control with short In-center versus long home hemodialysis. Blood Purification 2001;19(3):293-300. [MEDLINE: 11244189]
2. Cargill A, Watson AR. An evaluation of telecare to support patients receiving chronic peritoneal dialysis at home [abstract]. Peritoneal Dialysis International 2002;22(1):136. [CENTRAL: CN-00594560]
3. Castro L, Gahl G, Froese P, Kessel M. Comparison of effectiveness and frequency of complications in clinical continuous dialysis and home dialysis. Die Medizinische Welt 1971;22(24):1031. [CENTRAL: CN-00305035]
4. Chauveau P, Larroumet N, Desvergenes C, Montoriol J, Combe C, Aparicio M. A 3-year prospective study of the outcome of patients dialyzed at home or in self-care units [abstract]. Nephrology Dialysis Transplantation 1999;14(9):A184. [CENTRAL: CN-00483479]
5. De Smet R, Dhondt A, Eloot S, Claus S, Vanholder R. Nocturnal hemodialysis with the Genius® dialysis system [abstract no: FP327]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi128.
6. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. American Journal of Kidney Diseases 2001;38(2):371-6. [MEDLINE: 11479164]
7. Chan CT, Chertow GM, Daugirdas JT, Greene TH, Kotanko P, Larive B, et al. Effects of daily hemodialysis on heart rate variability: results from the frequent hemodialysis network (FHN) daily trial. Nephrology Dialysis Transplantation 2014;29(1):168-78. [MEDLINE: 24078335]
8. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circulation. Cardiovascular Imaging 2012;5(2):251-61. [MEDLINE: 22360996]
9. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clinical Journal of the American Society of Nephrology: CJASN 2013;8(12):2106-16. [MEDLINE: 23970131]
10. Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P, et al. Determinants of cardiac autonomic dysfunction in ESRD. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(10):1821-7. [MEDLINE: 20616163]
11. Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. Journal of the American Society of Nephrology 2012;23(4):727-38. [MEDLINE: 22362907]
12. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al. Effect of frequent hemodialysis on residual kidney function. Kidney International 2013;83(5):949-58. [MEDLINE: 23344474]
13. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In-center hemodialysis six times per week versus three times per week. New England Journal of Medicine 2010;363(24):2287-300. [MEDLINE: 21091062]
14. Frequent Hemodialysis Network (FHN). The Frequent Hemodialysis Network multicenter randomized trial of in-center daily hemodialysis [abstract no: F-PO009]. Journal of the American Society of Nephrology 2006;17(Abstracts):338A.
15. Frequent Hemodialysis Network (FHN) Trial Group. Progress of the frequent hemodialysis network randomized trial of in-center daily hemodialysis [abstract no: 61]. American Journal of Kidney Diseases 2007;49(4):A40. [CENTRAL: CN-00601916]
16. Greene T, Daugirdas J, Depner T, Gotch F, Kuhlmann M, Kotanko P, et al. Clearance and volume removal values for target dialysis prescriptions in the Frequent Hemodialysis Network (FHN) trials [abstract no: F-PO003]. Journal of the American Society of Nephrology 2006;17(Abstracts):337A. [CENTRAL: CN-00602073]
17. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M, Frequent Hemodialysis Network Study Group, et al. Solute clearances and fluid removal in the frequent hemodialysis network trials. American Journal of Kidney Diseases 2009;53(5):835-44. [MEDLINE: 19339093]
18. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning Frequent Hemodialysis Network (FHN) Randomized Trials. Clinical Journal of the American Society of Nephrology: CJASN 2012;7(5):782-94. [MEDLINE: 22422538]
19. Jhamb M, Tamura MK, Gassman J, Garg AX, Lindsay RM, Suri RS, et al. Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials. Blood Purification 2011;31(1-3):151-8. [MEDLINE: 21228584]
20. Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, et al. The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. Kidney International 2012;82(1):90-9. [MEDLINE: 22456602]
21. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, et al. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. American Journal of Kidney Diseases 2011;57(1):101-12. [MEDLINE: 21184919]
22. Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network Trials. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(8):1429-38. [MEDLINE: 20576825]
23. Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, et al. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. American Journal of Kidney Diseases 2013;61(2):228-37. [MEDLINE: 23149295]
24. Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, et al. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrology Dialysis Transplantation 2013;28(7):1888-98. [MEDLINE: 23358899]
25. Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, et al. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. American Journal of Kidney Diseases 2011;57(1):90-100. [MEDLINE: 21122961]
26. Sergeyeva O, Gorodetskaya I, Champagne J, Sherer S, Carter M. Recruitment successes and challenges in the frequent hemodialysis network (FHN) daily trial [abstract no: SU-FC058]. Journal of the American Society of Nephrology 2007;18(Abstracts):79A.
27. Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, et al. Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. Journal of Nephrology 2012;25(3):302-9. [MEDLINE: 22505248]
28. Stokes JB. Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation. Transactions of the American Clinical & Climatological Association 2011;122:124-36. [MEDLINE: 21686215]
29. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney International 2007;71(4):349-59. [MEDLINE: 17164834]
30. Suri RS, Larive B, Hall Y, Kimmel PL, Kliger AS, Levin N, et al. Effects of frequent hemodialysis on perceived caregiver burden in the Frequent Hemodialysis Network trials. Clinical Journal of the American Society of Nephrology: CJASN 2014;9(5):936-42. [MEDLINE: 24721892]
31. Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, et al. Risk of vascular access complications with frequent hemodialysis. Journal of the American Society of Nephrology 2013;24(3):498-505. [MEDLINE: 23393319]
32. Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, et al. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. American Journal of Kidney Diseases 2013;61(5):748-58. [MEDLINE: 23332990]
33. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circulation. Cardiovascular Imaging 2012;5(2):251-61. [MEDLINE: 22360996]
34. Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P, et al. Determinants of cardiac autonomic dysfunction in ESRD. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(10):1821-7. [MEDLINE: 20616163]
35. Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. Journal of the American Society of Nephrology 2012;23(4):727-38. [MEDLINE: 22362907]
36. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al. Effect of frequent hemodialysis on residual kidney function. Kidney International 2013;83(5):949-58. [MEDLINE: 23344474]
37. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In-center hemodialysis six times per week versus three times per week. New England Journal of Medicine 2010;363(24):2287-300. [MEDLINE: 21091062]
38. Frequent Hemodialysis Network (FHN) Trial Group. The Frequent Hemodialysis Network randomized trial of home nocturnal hemodialysis [abstract no: F-PO010]. Journal of the American Society of Nephrology 2006;17(Abstracts):338A. [CENTRAL: CN-00602072]
39. Frequent Hemodialysis Network (FHN) Trial Group. The Frequent Hemodialysis Network randomized trial of home nocturnal hemodialysis: change of trial design [abstract no: 62]. American Journal of Kidney Diseases 2007;49(4):A40.
40. Gassman JJ, Rocco M, Beck G, Larive B, Sherer S, Kliger A, et al. Changing a protocol early in a trial's vanguard phase: the Frequent Hemodialysis Network Home Nocturnal Hemodialysis Trial [abstract no: P71]. Clinical Trials 2007;4(4):421. [CENTRAL: CN-00782507]
41. Greene T, Daugirdas J, Depner T, Gotch F, Kuhlmann M, Kotanko P, et al. Clearance and volume removal values for target dialysis prescriptions in the Frequent Hemodialysis Network (FHN) trials [abstract no: F-PO003]. Journal of the American Society of Nephrology 2006;17(Abstracts):337A. [CENTRAL: CN-00602073]
42. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M, Frequent Hemodialysis Network Study Group, et al. Solute clearances and fluid removal in the frequent hemodialysis network trials. American Journal of Kidney Diseases 2009;53(5):835-44. [MEDLINE: 19339093]
43. Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning Frequent Hemodialysis Network (FHN) Randomized Trials. Clinical Journal of the American Society of Nephrology: CJASN 2012;7(5):782-94. [MEDLINE: 22422538]
44. Jhamb M, Tamura MK, Gassman J, Garg AX, Lindsay RM, Suri RS, et al. Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials. Blood Purification 2011;31(1-3):151-8. [MEDLINE: 21228584]
45. Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, et al. The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. Kidney International 2012;82(1):90-9. [MEDLINE: 22456602]
46. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, et al. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. American Journal of Kidney Diseases 2011;57(1):101-12. [MEDLINE: 21184919]
47. Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network Trials. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(8):1429-38. [MEDLINE: 20576825]
48. Kurella Tamura M, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, et al. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. American Journal of Kidney Diseases 2013;61(2):228-37. [MEDLINE: 23149295]
49. Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, et al. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrology Dialysis Transplantation 2013;28(7):1888-98. [MEDLINE: 23358899]
50. Pipkin M, Eggers PW, Larive B, Rocco MV, Stokes JB, Suri RS, et al. Recruitment and training for home hemodialysis: experience and lessons from the nocturnal dialysis trial. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(9):1614-20. [MEDLINE: 20576829]
51. Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, et al. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. American Journal of Kidney Diseases 2011;57(1):90-100. [MEDLINE: 21122961]
52. Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, et al. The effects of frequent nocturnal home hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial. Kidney International 2011;80(10):1080-91. [MEDLINE: 21775973]
53. Stokes JB. Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation. Transactions of the American Clinical & Climatological Association 2011;122:124-36. [MEDLINE: 21686215]
54. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney International 2007;71(4):349-59. [MEDLINE: 17164834]
55. Suri RS, Larive B, Hall Y, Kimmel PL, Kliger AS, Levin N, et al. Effects of frequent hemodialysis on perceived caregiver burden in the Frequent Hemodialysis Network trials. Clinical Journal of the American Society of Nephrology: CJASN 2014;9(5):936-42. [MEDLINE: 24721892]
56. Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, et al. Risk of vascular access complications with frequent hemodialysis. Journal of the American Society of Nephrology 2013;24(3):498-505. [MEDLINE: 23393319]
57. Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, et al. Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials. American Journal of Kidney Diseases 2013;61(5):748-58. [MEDLINE: 23332990]
58. Gutman RA, Blumenkrantz MJ, Chan YK, Barbour GL, Gandhi VC, Shen FH, et al. Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study. Kidney International 1984;26(4):459-70. [MEDLINE: 6396439]
59. Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J. A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodialysis International 2007;11(4):468-77. [MEDLINE: 17922746]
60. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrology Dialysis Transplantation 2000;15(1):58-64. [MEDLINE: 10607768]
61. Lynn KL, Buttimore AL, Inkster JA, Divakar D, Mylius AL, Ikram H, et al. Echocardiographic assessment of cardiac effects of erythropoietin in haemodialysis patients [abstract]. 9th Asian Colloquium in Nephrology; 1992 May 17-21; Seoul, Korea. 1992:183.
62. Lynn KL, Richards AM, Buttimore AL, Inkster JA, Bailey RR, Robson RA, et al. Placebo-controlled study of blood pressure and vasoactive hormones in haemodialysis patients on erythropoietin [abstract]. 9th Asian Colloquium in Nephrology; 1992 May 17-21; Seoul, Korea. 1992:183.
63. Shand BI, Buttimore AL, Hurrell MA, Wells JE, Inkster JA, Bailey RR, et al. Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study. Nephron 1993;64(1):53-7. [MEDLINE: 7880205]
64. Bass A, Ahmed SB, Klarenbach S, Culleton B, Hemmelgarn BR, Manns B. The impact of nocturnal hemodialysis on sexual function. BMC Nephrology 2012;13:67. [MEDLINE: 22834992]
65. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007;298(11):1291-9. [MEDLINE: 17878421]
66. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al. Nocturnal hemodialysis lowers blood pressure and reduces left ventricular mass: results of a randomized controlled trial [abstract no: SU-FC002]. Journal of the American Society of Nephrology 2007;18(Abstracts):67A-8A. [CENTRAL: CN-00783714]
67. Khangura J, Culleton BF, Manns BJ, Zhang J, Barnieh L, Walsh M, et al. Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrology 2010;11:13. [MEDLINE: 20576127]
68. Klarenbach S, Tonelli M, Pauly R, Walsh M, Culleton B, So H, et al. Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial. Journal of the American Society of Nephrology 2014;25(3):587-94. [MEDLINE: 24231665]
69. Manns BJ, Klarenbach S, Walsh M, Quinn R, Tonelli M, Scott-Douglas N, et al. The impact of nocturnal hemodialysis on quality of life: results of a randomized controlled trial [abstract no: F-PO891]. Journal of the American Society of Nephrology 2007;18(Abstracts):298A-9A. [CENTRAL: CN-00784458]
70. Manns BJ, Walsh MW, Culleton BF, Hemmelgarn B, Tonelli M, Schorr M, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney International 2009;75(5):542-9. [MEDLINE: 19109588]
71. Schorr M, Manns BJ, Culleton B, Walsh M, Klarenbach S, Tonelli M, et al. The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial. Journal of Renal Nutrition 2011;21(3):271-6. [MEDLINE: 20650654]
72. Walsh M, Manns B, Tonelli M, Quinn R, Culleton B. Description of a randomized controlled trial on the effects of nocturnal hemodialysis on left ventricular hypertrophy compared to conventional hemodialysis [abstract no: SA-PO815]. Journal of the American Society of Nephrology 2005;16:734A-5A. [CENTRAL: CN-00583210]
73. Walsh M, Manns BJ, Klarenbach S, Quinn R, Tonelli M, Culleton BF. The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study. BMC Nephrology 2006;7:2. [MEDLINE: 16504054]
74. Walsh M, Manns BJ, Klarenbach S, Tonelli M, Hemmelgarn B, Culleton B. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodialysis International 2010;14(2):174-81. [MEDLINE: 20041960]
75. Deziel C, Zellweger M, Comeau R, Kerangueven M, Raymond-Carrier S, Madore F. Hemodynamic stability during hemodialysis and quality of life with automated blood volume regulation: a prospective, randomized controlled trial.[abstract no: SU-FC014]. Journal of the American Society of Nephrology 2004;15(Oct):47A. [CENTRAL: CN-00583226]
76. Deziel C, Zellweger M, Comeau R, Valleau A, Raymond-Carrier S, Madore F. Home blood pressure management with automated blood volume regulation in hemodialysis patients: a prospective randomized controlled trial. [abstract no: SU-PO279]. Journal of the American Society of Nephrology 2004;15(Oct):594A. [CENTRAL: CN-00583224]
77. Zellweger M, Deziel C, Bui TN, Madore F. Hemodialysis tolerance is significantly improved with blood volume control (hemocontrol®) when aiming at a better blood pressure control by reducing dry weight [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:334. [CENTRAL: CN-00509576]
78. Agar JW. International variations and trends in home hemodialysis. Advances in Chronic Kidney Disease 2009;16(3):205-14. [MEDLINE: 19393971]
79. McDonald S, Excell L. Method and location of dialysis. In: Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Registry 2009 report. http://www.anzdata.org.au/anzdata/AnzdataReport/32ndReport/Ch04.pdf (accessed 30 October 2014).
80. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: a reexamination. American Journal of Kidney Diseases 1989;13(3):200-9. [MEDLINE: 2493190]
81. Cases A, Dempster M, Davies M, Gamble G. The experience of individuals with renal failure participating in home haemodialysis: An interpretative phenomenological analysis. Journal of Health Psychology 2011;16(6):884-94. [MEDLINE: 21447622]
82. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney International 1992; Vol. 41, issue 5:1286-91. [MEDLINE: 1614043]
83. Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney International 2006;69(9):1621-5. [MEDLINE: 16672923]
84. Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. Journal of Pain & Symptom Management 2010;39(3):477-85. [MEDLINE: 20303025]
85. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; Vol. 302, issue 16:1782-9. [MEDLINE: 19861670]
86. Evans RW, Manninen DL, Garrison LP Jr, Hart LG, Blagg CR, Gutman RA, et al. The quality of life of patients with end-stage renal disease. New England Journal of Medicine 1985; Vol. 312, issue 9:553-9. [MEDLINE: 3918267]
87. FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In-center hemodialysis six times per week versus three times per week. New England Journal of Medicine 2010; Vol. 363, issue 24:2287-300. [MEDLINE: 21091062]
88. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney International 2006; Vol. 69, issue 9:1662-8. [MEDLINE: 16598203]
89. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991; Vol. 265, issue 7:871-5. [MEDLINE: 1899455]
90. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated February 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
91. Jhamb M, Argyropoulos C, Steel JL, Plantinga L, Wu AW, Fink NE, et al. Correlates and outcomes of fatigue among incident dialysis patients. Clinical Journal of the American Society of Nephrology: CJASN 2009; Vol. 4, issue 11:1779-86. [MEDLINE: 19808226]
92. Kutner NG, Brogan D, Fielding B. Employment status and ability to work among working-age chronic dialysis patients. American Journal of Nephrology 1991;11(4):334-40. [MEDLINE: 1799194]
93. Mailloux LU, Bellucci AG, Mossey RT, Napolitano B, Moore T, Wilkes BM, et al. Predictors of survival in patients undergoing dialysis. American Journal of Medicine 1988;84(5):855-62. [MEDLINE: 3364444]
94. Marshall MR, Byrne BG, Kerr PG, McDonald SP. Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney International 2006;69(7):1229-36. [MEDLINE: 16609687]
95. McGregor D, Buttimore A, Robson R, Little P, Morton J, Lynn K. Thirty years of universal home dialysis in Christchurch. New Zealand Medical Journal 2000; Vol. 113, issue 1103:27-9. [MEDLINE: 11482325]
96. Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technology Assessment (Winchester, England) 2003;7(2):1-174. [MEDLINE: 12773260]
97. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. American Journal of Kidney Diseases 2010; Vol. 56, issue 4:670-85. [MEDLINE: 20801572]
98. Nitsch D, Steenkamp R, Tomson CR, Roderick P, Ansell D, MacGregor MS. Outcomes in patients on home haemodialysis in England and Wales, 1997-2005: a comparative cohort analysis. Nephrology Dialysis Transplantation 2010; Vol. 26, issue 5:1670-7. [MEDLINE: 20841489]
99. Roberts MA, Polkinghorne KR, McDonald SP, Ierino FL. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. American Journal of Kidney Diseases 2011;58(1):64-72. [MEDLINE: 21458896]
100. Saner E, Nitsch D, Descoeudres C, Frey FJ, Uehlinger DE. Outcome of home haemodialysis patients: a case-cohort study. Nephrology Dialysis Transplantation 2005; Vol. 20, issue 3:604-10. [MEDLINE: 15665030]
101. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney International 2006; Vol. 69, issue 7:1222-8. [MEDLINE: 16609686]
102. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, et al. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney International 2006; Vol. 71, issue 4:349-59. [MEDLINE: 17164834]
103. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM, Greene T, et al. Daily hemodialysis: a systematic review. Clinical Journal of The American Society of Nephrology: CJASN 2006;1(1):33-42. [MEDLINE: 17699188]
104. Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Chami H, et al. Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. American Journal of Kidney Diseases 2008; Vol. 52, issue 2:305-13. [MEDLINE: 18617308]
105. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010. http://www.usrds.org/atlas10.aspx (accessed 30 October 2014).
106. van Manen JG, Korevaar JC, Dekker FW, Reuselaars MC, Boeschoten EW, Krediet RT, et al. Changes in employment status in end-stage renal disease patients during their first year of dialysis. Peritoneal Dialysis International 2001; Vol. 21, issue 6:595-601. [MEDLINE: 11783769]
107. Vecchio M, Navaneethan SD, Johnson DW, Lucisano G, Graziano G, Saglimbene V, et al. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD007747.pub2]
108. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney International 2005;67(4):1500-8. [MEDLINE: 15780103]
109. Walsh M, Manns BJ, Klarenbach S, Tonelli M, Hemmelgarn B, Culleton B. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodialysis International 2010; Vol. 14, issue 2:174-81. [MEDLINE: 20041960]
110. Woods JD, Port FK, Stannard D, Blagg CR, Held PJ. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney International 1996; Vol. 49, issue 5:1464-70. [MEDLINE: 8731115]
111. Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, et al. Home versus in-centre haemodialysis for end-stage kidney disease. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD009535]